STONEGATE SYSTEMS

Public record · 2021-2026 · Source-linked

2026 Peptide Enforcement Tracker

Every public action against peptide sellers we track - FDA warning letters, a federal asset seizure, a criminal sentencing, and the July advisory votes - one line each, newest first, with a source on every line.

39 recorded actions · 36 warning letters · Updated July 26, 2026

What this pattern means if you run a store

  • Underwriters read this list before they read your application. Processor and bank risk desks search public enforcement records when they review a peptide merchant. A warning letter - or a storefront that reads like the ones below - is a decline or a termination before anyone looks at your volume.
  • Almost every action below started on the website, not in the warehouse. The letters quote sellers' own product pages, disclaimers, and cross-sells back at them. What they cite are patterns matching language quoted in published FDA warning letters - visible to any risk analyst who reads your site the same way the agency does.
  • A disclaimer is not a construction. The July 2026 sentencing involved sites labeled research-use-only throughout. Stores that hold accounts are the ones where compliance is enforced in code on every page and email - built to survive processor underwriting review, not to argue after the fact.
Run the free 60-second audit →

Scans your storefront against the trigger list from the letters below. Grade on screen, report in your inbox, no signup.

2026 12 actions

  1. Jul 23-24, 2026

    Advisory voteFDA Pharmacy Compounding Advisory Committee - over a two-day meeting, voted to recommend six of seven nominated research peptides for the Section 503A bulk compounding list, against the written position of FDA's own review staff; the seventh nomination was voted down. NPR · The Hill An advisory vote is not an approval and does not legalize retail sale. The recommendation is non-binding: FDA must still accept it and complete rulemaking, a process reported at 12-24 months - and it concerns licensed compounding pharmacies, not research-chemical storefronts.

  2. Jul 23, 2026

    SentencingU.S. Attorney's Office, W.D. Michigan - announced Brandon Piper was sentenced to 21 months in federal prison for a scheme importing unapproved, misbranded drugs from China and selling them online under "research purposes only" labeling that prosecutors said the sellers knew did not match how customers used the products. DOJ release

  3. Jun 17, 2026

    FDA letterWholesale Peptide - warning letter, unapproved new drugs / misbranded. FDA letter

  4. Jun 2026

    SeizureFederal agents, Missouri - seized four properties and multiple vehicles and froze bank accounts tied to Blome Research, an online peptide seller; court filings allege roughly $15 million in sales over about two and a half years. No criminal charges had been filed at the time of the seizure, per reporting. St. Louis Magazine

  5. May 1, 2026

    FDA letterHarbin Jixianglong Biotech Co., Ltd. - warning letter, CGMP / API / adulterated and misbranded drugs. FDA letter

  6. The March 31 batch: seven warning letters issued the same day - five to research-peptide storefronts and two to marketplace sellers of weight-control products - all citing unapproved new drugs, and all quoting the sellers' own pages past their research-use-only disclaimers.
  7. Mar 31, 2026

    FDA letterLovega LLC dba Pink Pony Peptides - warning letter, unapproved new drugs sold over the internet. FDA letter

  8. Mar 31, 2026

    FDA letterGram Peptides - warning letter, unapproved new drugs sold over the internet. FDA letter

  9. Mar 31, 2026

    FDA letterPrime Sciences - warning letter, unapproved new drugs sold over the internet; coded product names identified to their underlying compounds in the letter itself. FDA letter

  10. Mar 31, 2026

    FDA letterMile High Compounds LLC - warning letter, unapproved new drugs sold over the internet. FDA letter

  11. Mar 31, 2026

    FDA letterPekCura Labs - warning letter, unapproved new drugs sold over the internet. FDA letter

  12. Mar 31, 2026

    FDA letterFormPour - warning letter, unapproved new drug sold via an eBay storefront. FDA letter

  13. Mar 31, 2026

    FDA letterGuangzhou Huli Technology Co., Ltd. dba Fantasy Face - warning letter, unapproved new drug sold via an eBay storefront. FDA letter

2025 8 actions

  1. Dec 12, 2025

    FDA letterPinnacle Professional Research dba Pinnacle Peptides - warning letter, unapproved new drugs. FDA letter

  2. Dec 8, 2025

    FDA letterDarmerica, LLC - warning letter, CGMP / API / adulterated / misbranded. FDA letter

  3. Sep 9, 2025

    FDA letterybycmeds - warning letter, unlawful internet sale of unapproved and misbranded drugs to U.S. consumers (telehealth). FDA letter

  4. Sep 9, 2025

    FDA letterEli Lilly and Company - warning letter, false and misleading claims / misbranded. FDA letter

  5. Sep 9, 2025

    FDA letterEli Lilly and Company - second same-day warning letter, false and misleading claims / misbranded. FDA letter

  6. Sep 9, 2025

    FDA letterEli Lilly and Company - third same-day warning letter, false and misleading claims / misbranded. FDA letter

  7. Sep 9, 2025

    FDA letterNovo Nordisk Inc. - warning letter, false and misleading claims / misbranded. FDA letter

  8. Jun 12, 2025

    FDA letterwww.buynetmeds.com - warning letter, unlawful internet sale of unapproved and misbranded drugs to U.S. consumers. FDA letter

2024 7 actions

  1. Dec 10, 2024

    FDA letterPrime Vitality, Inc. dba Prime Peptides - warning letter, unapproved new drugs / misbranded. FDA letter

  2. Dec 10, 2024

    FDA letterSwisschems - warning letter, unapproved new drugs / misbranded. FDA letter

  3. Dec 10, 2024

    FDA letterXcel Research LLC - warning letter, unapproved new drugs / misbranded. FDA letter

  4. Dec 10, 2024

    FDA letterSummit Research Peptides - warning letter, unapproved new drugs / misbranded; the first modern letter aimed squarely at a research-peptide storefront. FDA letter

  5. Jun 12, 2024

    FDA letterWest Coast Laboratories, Inc. - warning letter, CGMP / dietary supplement / adulterated / misbranded. FDA letter

  6. Jun 12, 2024

    FDA letterAqualex Co., Ltd. - warning letter, CGMP / unapproved new drug / adulterated. FDA letter

  7. Feb 7, 2024

    FDA letterSynthetix Inc. dba Helix Chemical Supply - warning letter, unapproved new drugs / misbranded. FDA letter

2023 3 actions

  1. Oct 2, 2023

    FDA letterwww.semaspace.com - warning letter, unapproved new drug / misbranded. FDA letter

  2. Oct 2, 2023

    FDA letterwww.gorillahealing.com - warning letter, unapproved new drug / misbranded. FDA letter

  3. Jun 12, 2023

    FDA letterWarrior Labz SARMS - warning letter, unapproved new drugs / misbranded. FDA letter

2022 2 actions

  1. Dec 5, 2022

    FDA letterThriftmaster Texas, LLC dba ThriftMaster Global Holdings / TM Global Biosciences - warning letter, unapproved new drug / misbranded / adulterated foods. FDA letter

  2. May 26, 2022

    FDA letterPlantacea, LLC dba Kahm - warning letter (veterinary), unapproved new drugs / misbranded. FDA letter

2021 7 actions

  1. Nov 18, 2021

    FDA letterSaffron Health Sciences - warning letter, new drug / misbranded. FDA letter

  2. Oct 13, 2021

    FDA letterQuicksilver Scientific - warning letter, new drug / misbranded. FDA letter

  3. Jul 1, 2021

    FDA letterBiomedical Research Laboratories, LLC - warning letter, new drug / misbranded. FDA letter

  4. May 10, 2021

    FDA letterGreat Lakes Gelatin Company - warning letter, new drug / misbranded. FDA letter

  5. Apr 20, 2021

    FDA letterProper Nutrition Inc. - warning letter, new drug / misbranded. FDA letter

  6. Apr 13, 2021

    FDA letterOrphic Nutrition - warning letter, new drug / misbranded. FDA letter

  7. Feb 2, 2021

    FDA letterClarke Pharmaceutical Manufacturing, Inc. - warning letter, unapproved new drugs / misbranded. FDA letter

This tracker is updated automatically as new actions are published. Entries summarize public records - FDA warning letters, court filings, and agency announcements - with a source link on every line. Names above are entities named in those public records; inclusion reports the record, not commentary on anyone's character. Findings we describe are patterns matching language quoted in published FDA warning letters. This page is general information for store operators, not legal advice, and Stonegate Systems is not a law firm.

Free · Instant · No signup

Would your store survive the read that wrote these letters?

The 60-second scan checks your storefront against the trigger list from every letter on this page - dosing copy, cross-sells, review leakage, the works. Grade on screen, report in your inbox. The rules keep moving; a human keeps up.

Run my free audit → Book a build call →

Want it done for you? Peptide website design and development - live in 14 days.